Quest Diagnostics (NYSE:DGX – Free Report) had its target price upped by Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. Other research analysts have also recently issued research reports about the stock. SVB Leerink initiated coverage on […]
Signaturefd LLC grew its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 43.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,374 shares of the medical research company’s stock after purchasing an additional 418 shares during the quarter. Signaturefd […]
CALM’s Let’s Get Loud fundraiser, now in its 11th year, brought in more than $75,000 to support the prevention and treatment of childhood trauma in the
The Summer Music in the Park Series, presented every Wednesday by the Solvang Chamber of Commerce, will be returning starting at 5 p.m. June 19 with Sean
Schlumberger (NYSE:SLB – Free Report) had its price target cut by BMO Capital Markets from $66.00 to $64.00 in a research note released on Monday morning, Benzinga reports. They currently have an outperform rating on the oil and gas company’s stock. SLB has been the subject of several other research reports. Stifel Nicolaus boosted their […]